Nurse-Led Large Language Model Chatbot for Predicting and Preventing Complications After Coronary Artery Bypass Grafting: Protocol for a Randomized Controlled Trial
Nurse-gesteuerter Large-Language-Model-Chatbot zur Vorhersage und Prävention von Komplikationen nach Koronararterien-Bypass-Operation: Protokoll für eine randomisierte kontrollierte Studie
JMIR Research Protocols · 04.08.2026 · 15 · e103717-e103717
DOI: 10.2196/103717 ↗Auf einen Blick
Das Protokoll beschreibt Smart CABGuard, einen nurse-geführten LLM-Chatbot mit ECG-Monitoring nach isoliertem CABG. Geprüft werden Vorhersage und Prävention von Komplikationen und 30-Tage-Wiederaufnahmen.
Fragestellung
Kann Smart CABGuard nach isoliertem CABG postoperative Komplikationen und 30-Tage-Wiederaufnahmen verhindern?
Methode
Multiphase-Studie in Kochi, Indien; Phase III: prospektive, parallele, offene RCT mit 1:1-Randomisierung und Verblindung der Auswertenden.
Ergebnisse
Geplant sind 800 Patient:innen (400 je Arm). Interventionsarm: Smart CABGuard mit täglichen Check-ins, CRI-Risikostratifizierung, ECG-Monitoring und nurse-led Triage für etwa 24 Tage nach Entlassung; Kontrolle: Standardversorgung mit strukturierter Telefonnachverfolgung zur Ergebniserfassung.
Einschränkungen
Protokoll, daher keine Ergebnisse; Phase III-Rekrutierung erst für August 2026 bis September 2027 geplant.
Schlussfolgerung der Autor:innen
Smart CABGuard soll als erstes RCT-Protokoll eines LLM-basierten nurse-geführten CDS-Systems die Nützlichkeit, Sicherheit und Machbarkeit KI-gestützter postoperativer Überwachung prüfen.
Kernaussagen
- Phase III ist eine offene, parallele RCT nach isoliertem CABG
- Primärer Endpunkt: 30-Tage-Wiederaufnahme wegen jeglicher Ursache
- Ziel: 800 Patient:innen, 50 % relative Reduktion bei α=.10 und 80 % Power
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, online erschienen am 04.08.2026. Verfasst von Salini K und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Surgical Nursing, Amrita College of Nursing, Amrita Vishwa Vidyapeetham, Amrita Institute of Medical Sciences and Research Cent…. Hauptthemen laut MEDLINE: Coronary Artery Bypass, Postoperative Complications. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Thirty-day unplanned readmission following coronary artery bypass grafting (CABG) affects 10%-20% of patients and is a key quality indicator, particularly in low- and middle-income countries (LMICs) where access to cardiac rehabilitation is limited. Existing risk models are static, lack real-time engagement, and no validated large language model (LLM)–based clinical decision support (CDS) system exists for post-CABG readmission prevention.
Objective
This protocol describes the development, validation, and evaluation of Smart CABGuard, a nurse-led, LLM-based CDS chatbot with continuous remote electrocardiographic (ECG) monitoring, to predict and prevent postoperative complications, and 30-day unplanned readmission after isolated CABG.
Methods
This multiphase translational study is conducted at Amrita Institute of Medical Sciences, Kochi, India, following TRIPOD-LLM (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis–Large Language Model) and CONSORT (Consolidated Standards of Reporting Trials) AI reporting guidelines. Phase I uses an ambispective design (retrospective: January 2020 to December 2024; prospective needs survey: June 2025 to January 2026) to develop a logistic regression-based Complication Risk Index (CRI), assessed via receiver operating characteristic area under the curve, Brier score, and decision curve analysis. Phase II refines Smart CABGuard by integrating a frozen Mistral-7B LLM (low-rank adaptation fine-tuned), the CRI engine, explainable AI, and single-lead ECG telemetry (Amrita Spandanam device), with a usability threshold of ≥80%. Phase III is a prospective, parallel-group, open-label randomized controlled trial (RCT). Adults aged ≥18 years undergoing isolated CABG with smartphone access are randomized 1:1 via permuted block randomization, with allocation concealment. The intervention arm receives Smart CABGuard–assisted care (daily chatbot check-ins, CRI-based risk stratification, ECG monitoring, and nurse-led triage) for approximately 24 days postdischarge plus standard care; the control arm receives standard care with structured telephone follow-up for outcome ascertainment only. Outcome assessors and statisticians are blinded; analyses follow the intention-to-treat principle. The primary outcome is 30-day all-cause unplanned readmission. Based on a baseline rate of 10.71%, a 50% relative reduction, α=.10, and 80% power, the target sample size is 800 patients (400 per arm, including 10% attrition).
Results
Ethics approval was granted by the Institutional Ethics Committee of Amrita Institute of Medical Sciences on April 16, 2025. Funding was awarded by Sigma Theta Tau International Honor Society of Nursing, Small Grants Program (grant 21650) in June 2025. Phase I data extraction commenced in May 2025 and is projected to be completed by April 2026; the patient needs survey (June 2025 to January 2026) is ongoing. Phase II usability evaluation is projected from May to July 2026. Phase III recruitment is anticipated from August 2026 to September 2027. Results are expected to be published in early 2028.
Conclusions
Smart CABGuard is the first RCT protocol of an LLM-based nurse-led CDS system for post-CABG readmission prevention in an LMIC setting, aiming to establish the usefulness, safety, and feasibility of AI-augmented postoperative surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Surgical Nursing, Amrita College of Nursing, Amrita Vishwa Vidyapeetham, Amrita Institute of Medical Sciences and Research Center, Kochi Campus, Ponekkara, Edappally, Kochi, Kerala, 682041, India,…
- Department of Cardiovascular and Thoracic Surgery (CVTS), Amrita School of Medicine, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
- Department of Artificial Intelligence, Amrita School of Artificial Intelligence, Amrita Vishwa Vidyapeetham, Coimbatore, Tamil Nadu, India.
- Department of Medical Surgical Nursing, College of Nursing, Armed Forces Medical College, Pune, Maharashtra, India.
- Department of Medical Surgical Nursing, College of Nursing, RAK Medical & Health Sciences University, Al Juwais, Ras Al Khaimah, United Arab Emirates.
- Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
ORCID-Profile: Salini K, Ajee K L, Praveen Kerala Varma, Premjith B, Anila K P, Vandana Agnihotri, Priyalatha Muthu, Renjitha Bhaskaran, Namrata Nair
Zitieren
APA
K, S., K L, A., Kerala Varma, P., B, P., K P, A., Agnihotri, V., Muthu, P., Bhaskaran, R., & Nair, N. (2026). Nurse-Led Large Language Model Chatbot for Predicting and Preventing Complications After Coronary Artery Bypass Grafting: Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 15, e103717-e103717. https://doi.org/10.2196/103717
Vancouver
K S, K L A, Kerala Varma P, B P, K P A, Agnihotri V, et al. Nurse-Led Large Language Model Chatbot for Predicting and Preventing Complications After Coronary Artery Bypass Grafting: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e103717-e103717. doi:10.2196/103717
BibTeX
@article{K2026,
author = {K, Salini and K L, Ajee and Kerala Varma, Praveen and B, Premjith and K P, Anila and Agnihotri, Vandana and Muthu, Priyalatha and Bhaskaran, Renjitha and Nair, Namrata},
title = {Nurse-Led Large Language Model Chatbot for Predicting and Preventing Complications After Coronary Artery Bypass Grafting: Protocol for a Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2026},
volume = {15},
pages = {e103717--e103717},
doi = {10.2196/103717}
}
EUVIMED